Annals of the Rheumatic Diseases: 82 (1)

Editorial

Greetings from the editor 2023 (3 January, 2023) Free
Josef S Smolen

Recommendations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update (10 November, 2022) Free
Josef S Smolen, Robert B M Landewé, Sytske Anne Bergstra, Andreas Kerschbaumer, Alexandre Sepriano, Daniel Aletaha, Roberto Caporali, Christopher John Edwards, Kimme L Hyrich, Janet E Pope, Savia de Souza, Tanja A Stamm, Tsutomu Takeuchi, Patrick Verschueren, Kevin L Winthrop, Alejandro Balsa, Joan M Bathon, Maya H Buch, Gerd R Burmester, Frank Buttgereit, Mario Humberto Cardiel, Katerina Chatzidionysiou, Catalin Codreanu, Maurizio Cutolo, Alfons A den Broeder, Khadija El Aoufy, Axel Finckh, João Eurico Fonseca, Jacques-Eric Gottenberg, Espen A Haavardsholm, Annamaria Iagnocco, Kim Lauper, Zhanguo Li, Iain B McInnes, Eduardo F Mysler, Peter Nash, Gyula Poor, Gorica G Ristic, Felice Rivellese, Andrea Rubbert-Roth, Hendrik Schulze-Koops, Nikolay Stoilov, Anja Strangfeld, Annette van der Helm-van Mil, Elsa van Duuren, Theodora P M Vliet Vlieland, René Westhovens, Désirée van der Heijde
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update (21 October, 2022) Free
Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B M Landewé, Filip E Van den Bosch, Boryana Boteva, Ann Bremander, Philippe Carron, Adrian Ciurea, Floris A van Gaalen, Pál Géher, Lianne Gensler, Josef Hermann, Manouk de Hooge, Marketa Husakova, Uta Kiltz, Clementina López-Medina, Pedro M Machado, Helena Marzo-Ortega, Anna Molto, Victoria Navarro-Compán, Michael J Nissen, Fernando M Pimentel-Santos, Denis Poddubnyy, Fabian Proft, Martin Rudwaleit, Mark Telkman, Sizheng Steven Zhao, Nelly Ziade, Désirée van der Heijde
EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021 (20 June, 2022) Free
Marc H A Jansen, Christien Rondaan, Geertje E Legger, Kirsten Minden, Yosef Uziel, Natasa Toplak, Despoina Maritsi, Lotte van den Berg, Guy A M Berbers, Patricia Bruijning, Yona Egert, Christophe Normand, Marc Bijl, Helen E Foster, Isabelle Koné-Paut, Carine Wouters, Angelo Ravelli, Ori Elkayam, Nicolaas M Wulffraat, Marloes W Heijstek
2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases (8 March, 2022) Free
James M Gwinnutt, Maud Wieczorek, Andra Balanescu, Heike A Bischoff-Ferrari, Annelies Boonen, Giulio Cavalli, Savia de Souza, Annette de Thurah, Thomas E Dorner, Rikke Helene Moe, Polina Putrik, Javier Rodríguez-Carrio, Lucía Silva-Fernández, Tanja Stamm, Karen Walker-Bone, Joep Welling, Mirjana I Zlatković-Švenda, Francis Guillemin, Suzanne M M Verstappen
2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work (15 September, 2022) Free
Annelies Boonen, Casper Webers, Maarten Butink, Birgit Barten, Neil Betteridge, Dame Carol Black, Ann Bremander, Boryana Boteva, Olga Brzezińska, Lina Chauhan, Sarah Copsey, Vera Guimarães, Monique Gignac, Jennifer Glaysher, Frans Green, Jan L Hoving, Mary Lucy Marques, Hana Smucrova, Tanja A Stamm, Dieter Wiek, Ross Wilkie, Anthony D Woolf, Gerd R Burmester, Johannes W Bijlsma, Suzanne M M Verstappen
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseases (12 May, 2022) Free
Charlotte LM Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, Borja Hernández-Breijo, Guillaume Le Mélédo, Alejandro Balsa, Peter Böhm, Sasa Cucnik, Ori Elkayam, Guro L Goll, Femke Hooijberg, Meghna Jani, Patrick DW Kiely, Neil McCarthy, Denis Mulleman, Victoria Navarro-Compán, Katherine Payne, Martin E Perry, Chamaida Plasencia-Rodriguez, Simon R Stones, Silje Watterdal Syversen, Annick de Vries, Katherine M Ward, Gertjan Wolbink, John D Isaacs

Criteria

American College of Rheumatology/EULAR remission criteria for rheumatoid arthritis: 2022 revision (24 October, 2022)
Paul Studenic, Daniel Aletaha, Maarten de Wit, Tanja A Stamm, Farideh Alasti, Diane Lacaille, Josef S Smolen, David T Felson

Rheumatoid arthritis

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis (21 November, 2022)
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Désirée van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja A Stamm, Jan W Schoones, Josef S Smolen, Robert B M Landewé
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis (11 November, 2022)
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S Smolen, Désirée van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E Pope, Tsutomu Takeuchi, Kimme L Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja A Stamm, Jan W Schoones, Robert B M Landewé
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis (14 November, 2022)
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S Smolen, Désirée van der Heijde, Roberto Caporali, Christopher J Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme Hyrich, Kevin L Winthrop, Daniel Aletaha, Tanja Stamm, Jan W Schoones, Robert B M Landewé
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance (22 September, 2022)
Christina Charles-Schoeman, Maya H Buch, Maxime Dougados, Deepak L Bhatt, Jon T Giles, Steven R Ytterberg, Gary G Koch, Ivana Vranic, Joseph Wu, Cunshan Wang, Kenneth Kwok, Sujatha Menon, Jose L Rivas, Arne Yndestad, Carol A Connell, Zoltan Szekanecz

Axial spondyloarthritis

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis (21 October, 2022)
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B M Landewé, Sofia Ramiro, Désirée van der Heijde, Elena Nikiphorou
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis (19 October, 2022)
Augusta Ortolan, Casper Webers, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert BM Landewé, Sofia Ramiro, Désirée van der Heijde, Elena Nikiphorou

Paediatric rheumatology

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial (12 August, 2022)
Hermine I Brunner, Ivan Foeldvari, Ekaterina Alexeeva, Nuray Aktay Ayaz, Inmaculada Calvo Penades, Ozgur Kasapcopur, Vyacheslav G Chasnyk, Markus Hufnagel, Zbigniew Żuber, Grant Schulert, Seza Ozen, Adelina Rakhimyanova, Athimalaipet Ramanan, Christiaan Scott, Betul Sozeri, Elena Zholobova, Ruvie Martin, Xuan Zhu, Sarah Whelan, Luminita Pricop, Alberto Martini, Daniel Lovell, Nicolino Ruperto

Electronic pages

Correspondence to ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’ (30 October, 2020) Free
Hendrik Schulze-Koops, Alla Skapenko, Andreas Krause, Klaus Krueger, Hanns-Martin Lorenz, Philipp Sewerin, Christof Specker, Ulf G Wagner, Anna Voormann, Ulf Mueller-Ladner, Reinhard E Voll
Response to: ‘Correspondence on ‘Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases’’ by Schulze-Koops et al
(30 October, 2020) Free
Dalifer Dayanira Freites Nuñez, Leticia Leon, Arkaitz Mucientes, Luis Rodriguez-Rodriguez, Judit Font Urgelles, Alfredo Madrid García, Jose Ignacio Colomer, Juan A Jover, Benjamín Fernandez-Gutierrez, Lydia Abasolo
Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study (30 October, 2020) Free
Sergey Moiseev, Sergey Avdeev, Ekaterina Tao, Michail Brovko, Nikolay Bulanov, Anastasiia Zykova, Larisa Akulkina, Irina Smirnova, Victor Fomin
Response to ‘Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study’ by Moiseev et al
(30 October, 2020) Free
Sofia Ramiro, Robert B M Landewé, Rémy Mostard
Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’ (3 November, 2020) Free
Elisa Gremese, Giovanni Brondani, Luca Apollonio, Gianfranco Ferraccioli
Response to ‘Correspondence on ‘Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis’’ by Gremese et al
(3 November, 2020) Free
Shintaro Akiyama, Shadi Hamdeh, Dejan Micic, Atsushi Sakuraba
Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’ (3 November, 2020) Free
Sarah Stewart, Elizaveta Rakhmanova, Nicola Dalbeth
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al
(3 November, 2020) Free
Giovanni Adami, Camilla Benini, Elisabetta Vantaggiato, Denise Rotta, Ombretta Viapiana, Davide Gatti, Maurizio Rossini, Annamaria Iagnocco
Correspondence on ‘Tapering towards DMARD-free remission in rheumatoid arthritis’ (6 November, 2020) Free
Iveth Eunice García, Carlos Abud-Mendoza
Response to: ‘Correspondence on ‘Tapering towards DMARD-free remission in rheumatoid arthritis’ by Garcia et al
(6 November, 2020) Free
Elise van Mulligen, Pascal Hendrik Pieter de Jong
Correspondence on ‘Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease’ (2 November, 2020) Free
Gwo-Ping Jong, Lung-Fa Pan, Tsung-Kun Lin, Hung-Yi Chen
Response to ‘Correspondence on ‘Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease” by Jong et al
(2 November, 2020) Free
Brian Bridal Løgstrup, Kevin Kris Warnakula Olesen, Dzenan Masic, Christine Gyldenkerne, Pernille Gro Thrane, Torkell Ellingsen, Hans Erik Bøtker, Michael Maeng
Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’ (3 November, 2020) Free
Ran Cui, Qiang Tong, Zhi-Yong Chen, Miao Chen, Sheng-Ming Dai
Response to: ‘Correspondence on ‘Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study’’ by Cui et al
(3 November, 2020) Free
Ke-Qi Liu, Jiangwei Xia, Qiu-Ping Chen, Jian-Qiang Yang, Hou-Feng Zheng
Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’ (14 December, 2020) Free
Johan Rönnelid, Örjan Dahlström, Charlotte Dahle, Christopher Sjöwall
Response to: ‘Correspondence on ‘Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities’’ by Rönnelid et al
(14 December, 2020) Free
Sindhu R Johnson, Martin Aringer
Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia’ (3 November, 2020) Free
Hong Huang, Zhuoli Zhang
Response to: ‘Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia’’ by Huang and Zhang (3 November, 2020) Free
Han-You Mo, James Cheng Chung Wei, Xiao-Huan Chen, Hsin-Hua Chen
Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study’ (20 November, 2020) Free
George N Goulielmos, Maria I Zervou
Response to: ‘Correspondence on ‘Increased risk of systemic lupus erythematosus in patients with autoimmune haemolytic anaemia: a nationwide population-based cohort study’’ by Goulielmos and Zervou (20 November, 2020) Free
Han-You Mo, Xiao-Huan Chen, James Cheng Chung Wei, Hsin-Hua Chen
Correspondence on ‘Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement’ (6 November, 2020) Free
Mirko Manetti
Response to: ‘Correspondence on ‘Machine learning integration of scleroderma histology and gene expression identifies fibroblast polarisation as a hallmark of clinical severity and improvement’’ by Manetti (6 November, 2020) Free
Kimberly Showalter, Cynthia Magro, Yaxia Zhang, Robert Spiera, Dana E Orange, Jessica K Gordon
Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’ (4 February, 2021) Free
Akshay Parikh, Phani Kumar Devarasetti, Liza Rajasekhar
Response to: ‘Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’’ by Parikh et al
(4 February, 2021) Free
Rona M Smith, Peter A Merkel, David Jayne
Case of adult large vessel vasculitis after SARS-CoV-2 infection (11 August, 2020) Free
Ryohei Oda, Takeshi Inagaki, Masahiro Ishikane, Masatoshi Hotta, Akira Shimomura, Mitsuhiro Sato, Takato Nakamoto, Yutaro Akiyama, Kei Yamamoto, Ryogo Minamimoto, Hiroshi Kaneko, Norio Ohmagari
Analysis on misdiagnosis of a case of novel variant of NLRP12 (31 August, 2020) Free
Xiran Yang, Bo Zhao, Yabin Liao
COP27 climate change conference: urgent action needed for Africa and the world (18 October, 2022)
Chris Zielinski

Main menu

Table of contents

January 2023 - Volume 82 - 1

Editorial

Recommendations

Criteria

Rheumatoid arthritis

Axial spondyloarthritis

Paediatric rheumatology

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

January 2023 - Volume 82 - 1

Editorial

Recommendations

Criteria

Rheumatoid arthritis

Axial spondyloarthritis

Paediatric rheumatology

Electronic pages

Issue Information